Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2002 Nov 30;325(7375):1302; author reply 1302.
doi: 10.1136/bmj.325.7375.1302/a.

Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justified

Comment

Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justified

Hilary Calvert et al. BMJ. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Innovative anticancer agents approved in Italy: comparison between price range or “negotiation window” proposed by pharmacoeconomic algorithm (horizontal line) and final price approved by the negotiation committee (vertical circle)

Comment on

References

    1. Garattini S, Bertele' V. Efficacy, safety, and cost of new anticancer drugs. BMJ. 2002;325:269–272. . (3 August.) - PMC - PubMed
    1. Nabholz JM, Tonkin K, Smylie M, Au H-J, Lindsay M-A, Mackey J. Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer? Exp Opin Pharmacother. 2000;1:187–206. - PubMed
    1. Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E, et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results. J Natl Cancer Inst. 2000;92:699–708. - PubMed
    1. Richards MA, Stockton D, Coleman P. How many deaths have been avoided through improvements in cancer survival? BMJ. 2000;320:895–898. - PMC - PubMed
    1. Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol. 2001;19:4097–4106. - PubMed

Substances